全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Hideyuki Harada , Shinya Hayashi ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (5), pp.849-856
摘要:To investigate the maximum tolerated dose (MTD) and recommended dose (RD) of stereotactic body radiation therapy (SBRT) for centrally located stage IA non-small cell lung cancer (NSCLC).
作者:Hideyuki Harada , Sunao Tokumaru ...
来源:[J].International Journal of Radiation Oncology, Biology, Physics(IF 4.524), 2020, Vol.106 (1), pp.82-89
摘要:Purpose(#br)To investigate the efficacy and safety of proton beam therapy (PBT) for the treatment of stage I non-small cell lung cancer (NSCLC).(#br)Methods and Materials(#br)Six hundred sixty-nine patients with 682 tumors histologically or clinically diagnosed stage I NSCLC...
作者:Hideyuki Harada , Noboru Yamamoto ...
来源:[J].Lung Cancer(IF 3.392), 2017, Vol.108, pp.232-237
摘要:Abstract(#br)Objectives(#br)The objective of this study was to select, for a phase III trial, the more promising of weekly-dose intensive chemotherapy or amrubicin + cisplatin chemotherapy as subsequent therapy after induction chemoradiotherapy for previously untreated limit...
作者:Hideyuki Harada , Koichi Mitsuya ...
来源:[J].International Journal of Radiation Oncology, Biology, Physics(IF 4.524), 2019
摘要:Abstract(#br)Background(#br)It is unclear if local therapy or EGFR-TKI should take precedence for EGFR-mutant non-small cell lung cancer (NSCLC) patients with brain metastases (BMs). The number of BMs is important in the choice of local therapy including Whole-brain radiothe...
作者:Hideyuki Harada , Shoji Tokunaga ...
来源:[J].Clinical Lung Cancer(IF 2.038), 2018
摘要:Abstract(#br)Background(#br)Locally advanced non-small cell lung cancer (LA-NSCLC) is curable. Standard treatment is concurrent chemoradiotherapy (CRT), but its efficacy with cytotoxic agents seems to reach a plateau. Among advanced NSCLC patients who have epidermal growth factor...
作者:Hideyuki Harada , Tateaki Naito ...
来源:[J].SpringerPlus, 2015, Vol.4 (1), pp.1-10
摘要:Abstract(#br)Platinum-based chemoradiotherapy (CRT) is a standard front-line treatment for locally advanced non-small cell lung cancer (NSCLC). However, no clinical trials have compared the efficacy and toxicity of platinum combination and docetaxel as subsequent re-challeng...
作者:Hideyuki Harada , Makoto Nishio ...
来源:[J].Clinical Lung Cancer(IF 2.038), 2013, Vol.14 (4), pp.440-445
摘要:Abstract(#br)Purpose(#br)To determine the recommended dose (RD) in concurrent conformal radiotherapy with S-1 and cisplatin chemotherapy for inoperable stage III non–small-cell lung cancer.(#br)Patients and Methods(#br)Eligible patients with inoperable stage III non–small-ce...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×